Viewing Study NCT00390403


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-05-18 @ 3:58 PM
Study NCT ID: NCT00390403
Status: COMPLETED
Last Update Posted: 2012-05-03
First Post: 2006-10-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NABTT-0602 CDR0000507451
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View